Abcellera presents data showing preclinical efficacy of psma x cd3 t-cell engagers at aacr 2025

Vancouver, british columbia--(business wire)---- $abcl--abcellera presents data showing preclinical efficacy of psma x cd3 t-cell engagers at aacr 2025.

ABCL Ratings Summary

ABCL Quant Ranking